Figure 1: Classes Age in Southern Moroccan Hemoglobinopathies Patients.
Parameters |
Values |
Hemoglobin: |
2,3 - 13,4 g/dl |
MCV |
44 - 115 μ³, |
MCHC |
15 - 32,9 |
RBC |
3000 - 6000/mm3 |
platelets |
54000/mm3 - 315000/mm3 |
Reticulocytes |
15500 - 945000 g/l |
Table 1: Variable parameters in blood count of hemoglobinopathies patients
|
Sum of squares |
ddl |
Mean of squares |
F |
Signification |
|
HB_A2 |
Intergroupes |
1532,832 |
25 |
61,313 |
145,761 |
0 ,000 |
Intra-groupes |
55,525 |
132 |
0 ,421 |
|
|
|
Total |
1588,357 |
157 |
|
|
|
|
HB_A2 |
Intergroupes |
1502,218 |
25 |
60,089 |
138,617 |
0 ,000 |
Intra-groupes |
57,220 |
132 |
0 ,433 |
|
|
|
Total |
1559,438 |
157 |
|
|
|
Table 2: ANOVA TEST of HbA2 values in pathological patients
DISEASE TYPE |
Hb Anomalies |
Percentage |
Total |
Beta- thalassemia (BT) |
HTZ BT |
14% |
17% |
HMZ BT |
3% |
||
Drepanocytosis (S) |
A /S |
7,5% |
10,5% |
SS OU SB |
3% |
||
Hemoglobin C |
CC |
2% |
6,6% |
CA |
4% |
||
C Beta-thalassemia |
0.6% |
||
Alpha-thalassemia |
Alpha |
1,2% |
1,2% |
Iron deficiency |
Carence |
14,5% |
14,5% |
Elevated Hb F |
HbF <5% (nl Hemogram) |
4,4% |
4,4% |
Delta-BT |
Hb F>5% (Hb A2 normal or low) |
2,5% |
2,5% |
Hb O Arabe |
HTZ O Arabe Hb |
0,6% |
1,2% |
O Arabe/ BT |
0,6% |
Table 3: Hemoglobinopathies profile in southern Morocco (this study).
Hb Type |
Type |
HB_A2 |
HB_A2Bis |
HB_F |
HB_FBis |
AA |
NORMAL |
2,6 |
3,2 |
1,6 |
1,9 |
HTZ Beta- Thalassemia |
A / BT |
4,3 |
7,2 |
0,0 |
3,7 |
B/B |
3,1 |
7,3 |
25,9 |
97,9 |
|
Drepanocytosis |
S/S |
2,2 |
6,2 |
6,8 |
21,3 |
S /B |
0,3 |
3,3 |
11,2 |
14,1 |
|
A/S |
2,8 |
4,4 |
0,0 |
2,9 |
|
Hemoglobin C |
AC |
2,8 |
3,3 |
0,2 |
0,4 |
C/B |
4,3 |
4,8 |
0,8 |
1,0 |
|
CC |
0,0 |
3,8 |
0,0 |
0,6 |
|
Delta beta thal |
Delta BT |
2,0 |
2,8 |
5,5 |
9,2 |
00%<Hb F<5% |
Elevated Hb F |
2,8 |
2,9 |
1,6 |
2,3 |
Alpha thalassemia |
Minor alpha thalassemia |
1,7 |
2,5 |
,0 |
0,0 |
O Arabe Hb |
O arabe /BT |
6,0 |
6,4 |
9,3 |
10,3 |
Htz O Arabe |
39,4 |
40,0 |
,0 |
,0 |
Table 4: Hb A2 and F Values Means in Different Hemoglobinopathies Type in Our Study.
Tables at a glance
Figures at a glance